Skip to main content
Erschienen in: International Journal of Clinical Oncology 1/2016

01.02.2016 | Original Article

Gender differences in colorectal cancer survival in Japan

verfasst von: Kenjiro Kotake, Michio Asano, Heita Ozawa, Hirotoshi Kobayashi, Kenichi Sugihara

Erschienen in: International Journal of Clinical Oncology | Ausgabe 1/2016

Einloggen, um Zugang zu erhalten

Abstract

Background

A gender difference in survival has been documented in colorectal cancer (CRC) patients, although the underlying mechanism remains undefined. This study aimed to gain improved insight into this difference, with a special focus on improved cancer-specific survival.

Methods

The study population consisted of 82,402 patients with invasive CRC who had undergone surgery in Japan between 1985 and 2004. To estimate improved survival, multivariate adjustment using patient demographics and tumor characteristics was performed.

Results

Patient characteristics changed over time. The 5-year survival rates increased from 66.5 to 76.3 % during the study period. Higher survival rates persisted in women over time (multivariate-adjustment model—hazard ratio [HR] 0.87, 95 % confidence interval [CI] 0.85–0.90). Patients who received surgery during the period 2000–2004 had significantly longer survival than those during the period 1985–1989 (men: HR 0.70, 95 % CI 0.67–0.74; women: HR 0.72, 95 % CI 0.67–0.76). However, there was no gender difference regarding improved survival.

Conclusions

A reduced risk of cancer-specific death for women relative to men persisted over time; however, enhancement of survival was equally observed in both genders. Identification of factors associated with gender differences and changes over time in CRC survival may serve as targets for further improvement.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Ferlay J, Soerjomataram I, Ervik M et al (2013) GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer. http://globocan.iarc.fr. Accessed on 27 Apr 2015 Ferlay J, Soerjomataram I, Ervik M et al (2013) GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer. http://​globocan.​iarc.​fr. Accessed on 27 Apr 2015
2.
Zurück zum Zitat Gao RN, Neutel CI, Wai E (2008) Gender differences in colorectal cancer incidence, mortality, hospitalizations and surgical procedures in Canada. J Public Health (Oxf) 30(2):194–201CrossRef Gao RN, Neutel CI, Wai E (2008) Gender differences in colorectal cancer incidence, mortality, hospitalizations and surgical procedures in Canada. J Public Health (Oxf) 30(2):194–201CrossRef
3.
Zurück zum Zitat Cheng X, Chen VW, Steele B et al (2001) Subsite-specific incidence rate and stage of disease in colorectal cancer by race, gender, and age group in the United States, 1992–1997. Cancer 92(10):2547–2554CrossRefPubMed Cheng X, Chen VW, Steele B et al (2001) Subsite-specific incidence rate and stage of disease in colorectal cancer by race, gender, and age group in the United States, 1992–1997. Cancer 92(10):2547–2554CrossRefPubMed
4.
Zurück zum Zitat Allemani C, Weir HK, Carreira H, CONCORD Working Group et al (2015) Global surveillance of cancer survival 1995–2009: analysis of individual data for 25,676,887 patients from 279 population-based registries in 67 countries (CONCORD-2). Lancet 385(9972):977–1010CrossRefPubMed Allemani C, Weir HK, Carreira H, CONCORD Working Group et al (2015) Global surveillance of cancer survival 1995–2009: analysis of individual data for 25,676,887 patients from 279 population-based registries in 67 countries (CONCORD-2). Lancet 385(9972):977–1010CrossRefPubMed
5.
Zurück zum Zitat Zeng C, Wen W, Morgans A et al (2015) Disparities by race, age, and sex in the improvement of survival for major cancers: results from the National Cancer Institute Surveillance, Epidemiology, and End Results (SEER) Program in the United States, 1990 to 2010. JAMA Oncol 1(1):88–96CrossRefPubMed Zeng C, Wen W, Morgans A et al (2015) Disparities by race, age, and sex in the improvement of survival for major cancers: results from the National Cancer Institute Surveillance, Epidemiology, and End Results (SEER) Program in the United States, 1990 to 2010. JAMA Oncol 1(1):88–96CrossRefPubMed
6.
Zurück zum Zitat Matsuda T, Ajiki W, Marugame T et al, Research Group of Population-Based Cancer Registries of Japan: monitoring of Cancer Incidence in Japan—Survival 2003–2005 Report (Center for Cancer Control and Information Services, National Cancer Center, 2013) (2011) Population-based survival of cancer patients diagnosed between 1993 and 1999 in Japan: a chronological and international comparative study. Jpn J Clin Oncol 41:40–51CrossRefPubMed Matsuda T, Ajiki W, Marugame T et al, Research Group of Population-Based Cancer Registries of Japan: monitoring of Cancer Incidence in Japan—Survival 2003–2005 Report (Center for Cancer Control and Information Services, National Cancer Center, 2013) (2011) Population-based survival of cancer patients diagnosed between 1993 and 1999 in Japan: a chronological and international comparative study. Jpn J Clin Oncol 41:40–51CrossRefPubMed
7.
Zurück zum Zitat André T, Boni C, Mounedji-Boudiaf L et al (2004) Multicenter International Study of Oxaliplatin/5-Fluorouracil/Leucovorin in the Adjuvant Treatment of Colon Cancer (MOSAIC) Investigators: oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. N Engl J Med 350(23):2343–2351CrossRefPubMed André T, Boni C, Mounedji-Boudiaf L et al (2004) Multicenter International Study of Oxaliplatin/5-Fluorouracil/Leucovorin in the Adjuvant Treatment of Colon Cancer (MOSAIC) Investigators: oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. N Engl J Med 350(23):2343–2351CrossRefPubMed
8.
Zurück zum Zitat Kopetz S, Chang GJ, Overman MJ et al (2009) Improved survival in metastatic colorectal cancer is associated with adoption of hepatic resection and improved chemotherapy. J Clin Oncol 27(22):3677–3683PubMedCentralCrossRefPubMed Kopetz S, Chang GJ, Overman MJ et al (2009) Improved survival in metastatic colorectal cancer is associated with adoption of hepatic resection and improved chemotherapy. J Clin Oncol 27(22):3677–3683PubMedCentralCrossRefPubMed
9.
Zurück zum Zitat Matsuda A, Matsuda T, Shibata A et al (2013) Cancer Incidence and Incidence Rates in Japan in 2008: a Study of 25 Population-based Cancer Registries for the Monitoring of Cancer Incidence in Japan (MCIJ) Project. Jpn J Clin Oncol 44(4):388–396CrossRef Matsuda A, Matsuda T, Shibata A et al (2013) Cancer Incidence and Incidence Rates in Japan in 2008: a Study of 25 Population-based Cancer Registries for the Monitoring of Cancer Incidence in Japan (MCIJ) Project. Jpn J Clin Oncol 44(4):388–396CrossRef
11.
Zurück zum Zitat Kotake K, Honjo S, Sugihara K et al (2003) Changes in colorectal cancer during a 20-year period: an extended report from the multi-institutional registry of large bowel cancer, Japan. Dis Colon Rectum 46(10 Suppl):S32–S43PubMed Kotake K, Honjo S, Sugihara K et al (2003) Changes in colorectal cancer during a 20-year period: an extended report from the multi-institutional registry of large bowel cancer, Japan. Dis Colon Rectum 46(10 Suppl):S32–S43PubMed
12.
Zurück zum Zitat Rhodes JB, Holmes FF, Clark GM (1997) Changing distribution of primary cancers in the large bowel. JAMA 238(15):1641–1643CrossRef Rhodes JB, Holmes FF, Clark GM (1997) Changing distribution of primary cancers in the large bowel. JAMA 238(15):1641–1643CrossRef
13.
Zurück zum Zitat Ji BT, Devesa SS, Chow WH et al (1998) Colorectal cancer incidence trends by subsite in urban Shanghai, 1972–1994. Cancer Epidemiol Biomark Prev 7(8):661–666 Ji BT, Devesa SS, Chow WH et al (1998) Colorectal cancer incidence trends by subsite in urban Shanghai, 1972–1994. Cancer Epidemiol Biomark Prev 7(8):661–666
14.
Zurück zum Zitat Wichmann MW, Müller C, Hornung HM et al (2001) Gender differences in long-term survival of patients with colorectal cancer. Br J Surg 88(8):1092–1098CrossRefPubMed Wichmann MW, Müller C, Hornung HM et al (2001) Gender differences in long-term survival of patients with colorectal cancer. Br J Surg 88(8):1092–1098CrossRefPubMed
15.
Zurück zum Zitat McArdle CS, McMillan DC, Hole DJ (2003) Male gender adversely affects survival following surgery for colorectal cancer. Br J Surg 90(6):711–715CrossRefPubMed McArdle CS, McMillan DC, Hole DJ (2003) Male gender adversely affects survival following surgery for colorectal cancer. Br J Surg 90(6):711–715CrossRefPubMed
16.
Zurück zum Zitat Paulson EC, Wirtalla C, Armstrong K et al (2009) Gender influences treatment and survival in colorectal cancer surgery. Dis Colon Rectum 52(12):1982–1991CrossRefPubMed Paulson EC, Wirtalla C, Armstrong K et al (2009) Gender influences treatment and survival in colorectal cancer surgery. Dis Colon Rectum 52(12):1982–1991CrossRefPubMed
17.
Zurück zum Zitat Siegel R, DeSantis C (2014) Colorectal cancer statistics, 2014. CA Cancer J Clin 64(2):104–117CrossRefPubMed Siegel R, DeSantis C (2014) Colorectal cancer statistics, 2014. CA Cancer J Clin 64(2):104–117CrossRefPubMed
18.
Zurück zum Zitat Verschueren RC, Mulder NH, Van Loon AJ et al (1997) The anatomical substrate for a differences in surgical approach to rectal cancer in male and female patients. Anticancer Res 17(1B):637–641PubMed Verschueren RC, Mulder NH, Van Loon AJ et al (1997) The anatomical substrate for a differences in surgical approach to rectal cancer in male and female patients. Anticancer Res 17(1B):637–641PubMed
19.
Zurück zum Zitat Fietkau R, Rödel C, Hohenberger W et al (2007) Rectal cancer delivery of radiotherapy in adequate time and with adequate dose is influenced by treatment center, treatment schedule, and gender and is prognostic parameter for local control: results of study CAO/ARO/AIO-94. Int J Radiat Oncol Biol Phys 67(4):1008–1019CrossRefPubMed Fietkau R, Rödel C, Hohenberger W et al (2007) Rectal cancer delivery of radiotherapy in adequate time and with adequate dose is influenced by treatment center, treatment schedule, and gender and is prognostic parameter for local control: results of study CAO/ARO/AIO-94. Int J Radiat Oncol Biol Phys 67(4):1008–1019CrossRefPubMed
20.
Zurück zum Zitat Slattery ML, Friedman GD, Potter JD et al (1996) A description of age, sex, and site distributions of colon carcinoma in three geographic areas. Cancer 78(8):1666–1670CrossRefPubMed Slattery ML, Friedman GD, Potter JD et al (1996) A description of age, sex, and site distributions of colon carcinoma in three geographic areas. Cancer 78(8):1666–1670CrossRefPubMed
21.
22.
Zurück zum Zitat McMillan DC, Wotherspoon HA, Fearon KC et al (1995) A prospective study of tumor recurrence and the acute-phase response after apparently cur active colorectal cancer surgery. Am J Surg 170(4):319–322CrossRefPubMed McMillan DC, Wotherspoon HA, Fearon KC et al (1995) A prospective study of tumor recurrence and the acute-phase response after apparently cur active colorectal cancer surgery. Am J Surg 170(4):319–322CrossRefPubMed
23.
Zurück zum Zitat Ward R, Meagher A, Tomlinson I et al (2001) Microsatellite instability and the clinicopathological features of sporadic colorectal cancer. Gut 48(6):821–829PubMedCentralCrossRefPubMed Ward R, Meagher A, Tomlinson I et al (2001) Microsatellite instability and the clinicopathological features of sporadic colorectal cancer. Gut 48(6):821–829PubMedCentralCrossRefPubMed
24.
Zurück zum Zitat Hawkins N, Norrie M, Cheong K et al (2002) CpG island methylation in sporadic colorectal cancers and its relationship to microsatellite instability. Gastroenterology 122(5):1376–1387CrossRefPubMed Hawkins N, Norrie M, Cheong K et al (2002) CpG island methylation in sporadic colorectal cancers and its relationship to microsatellite instability. Gastroenterology 122(5):1376–1387CrossRefPubMed
25.
Zurück zum Zitat Ogino S, Cantor M, Kawasaki T et al (2006) CpG island methylator phenotype (CIMP) of colorectal cancer is best characterised by quantitative DNA methylation analysis and prospective cohort studies. Gut 55(7):1000–1006PubMedCentralCrossRefPubMed Ogino S, Cantor M, Kawasaki T et al (2006) CpG island methylator phenotype (CIMP) of colorectal cancer is best characterised by quantitative DNA methylation analysis and prospective cohort studies. Gut 55(7):1000–1006PubMedCentralCrossRefPubMed
26.
Zurück zum Zitat Martling A, Granath F, Cedermark B et al (2009) Gender differences in the treatment of rectal cancer: a population based study. Eur J Surg Oncol 35(4):427–433CrossRefPubMed Martling A, Granath F, Cedermark B et al (2009) Gender differences in the treatment of rectal cancer: a population based study. Eur J Surg Oncol 35(4):427–433CrossRefPubMed
27.
Zurück zum Zitat Rayson D, Urquhart R, Cox M et al (2012) Adherence to clinical practice guidelines for adjuvant chemotherapy for colorectal cancer in a Canadian province: a population-based analysis. J Oncol Pract 8(4):253–259PubMedCentralCrossRefPubMed Rayson D, Urquhart R, Cox M et al (2012) Adherence to clinical practice guidelines for adjuvant chemotherapy for colorectal cancer in a Canadian province: a population-based analysis. J Oncol Pract 8(4):253–259PubMedCentralCrossRefPubMed
28.
Zurück zum Zitat Jessup JM, Stewart A, Greene FL et al (2005) Adjuvant chemotherapy for stage III colon cancer: implications of race/ethnicity, age, and differentiation. JAMA 294(21):2703–2711CrossRefPubMed Jessup JM, Stewart A, Greene FL et al (2005) Adjuvant chemotherapy for stage III colon cancer: implications of race/ethnicity, age, and differentiation. JAMA 294(21):2703–2711CrossRefPubMed
29.
Zurück zum Zitat Verschueren RC, Mulder NH, Van Loon AJ et al (1997) The anatomical substrate for a differences in surgical approach to rectal cancer in male and female patients. Anticancer Res 17(1B):637–641PubMed Verschueren RC, Mulder NH, Van Loon AJ et al (1997) The anatomical substrate for a differences in surgical approach to rectal cancer in male and female patients. Anticancer Res 17(1B):637–641PubMed
Metadaten
Titel
Gender differences in colorectal cancer survival in Japan
verfasst von
Kenjiro Kotake
Michio Asano
Heita Ozawa
Hirotoshi Kobayashi
Kenichi Sugihara
Publikationsdatum
01.02.2016
Verlag
Springer Japan
Erschienen in
International Journal of Clinical Oncology / Ausgabe 1/2016
Print ISSN: 1341-9625
Elektronische ISSN: 1437-7772
DOI
https://doi.org/10.1007/s10147-015-0868-6

Weitere Artikel der Ausgabe 1/2016

International Journal of Clinical Oncology 1/2016 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.